Yüklüyor......

Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer

For many years, preclinical and clinical studies have attempted to harness the power of the immune system and focus it on malignant cells in an attempt to improve clinical outcomes for patients with cancer. The current paper describes the landmark phase III trial that led to the first U.S. Food and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Madan, Ravi A., Gulley, James L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3474245/
https://ncbi.nlm.nih.gov/pubmed/21174555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.10.77
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!